NCT00004333View on ClinicalTrials.gov

Phase II Study of the Enzyme Inhibitor NTBC for Tyrosinemia Type I

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

November 30, 1994

Conditions
Tyrosinemia, Type I
Interventions
DRUG

NTBC

All Listed Sponsors
collaborator

University of Michigan

OTHER

lead

National Center for Research Resources (NCRR)

NIH